Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Study in Rural Area

What this Trial Is About

This research aims to improve care for patients with osteoporosis and fractures by establishing a Fragility Fracture Liaison Service (FLS) and an anti-osteoporosis medication management service at the National Taiwan University Hospital Jinshan Branch. The study addresses gaps found in previous research, where only a fraction of fracture patients received bone density tests or treatments, and medication adherence was low. The goal is to better monitor and manage osteoporosis treatment and fracture prevention in patients aged 50 and older. The program enrolls patients with new hip fractures, newly identified vertebral fractures, or those prescribed anti-osteoporosis medications with issues such as recent medication changes or poor adherence. Patients are referred by their physicians and receive baseline assessments of fracture and osteoporosis risks. Care managers provide education on osteoporosis, fractures, sarcopenia, falls, medications, nutrition, and exercise. They also arrange follow-up visits and phone reminders, coordinate with healthcare providers, and support medication adherence through reminders and clinic visits for injections. Participants are assessed at the start and every four months for two years, with a total enrollment target of 200 patients. Researchers track medication adherence, provide osteoporosis-related advice, and monitor fall and fracture incidences during follow-up. The study collects data to build a patient database, helping healthcare providers improve osteoporosis management skills and increase adherence to anti-osteoporosis medications.

Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study